with Severe Dengue Infection in adult and children during the 2011 epidemic in Chonburi, Thailand. Thailand: Trop med Int Health

(1)

73 DAFTAR PUSTAKA

1. World Health Organization

(WHO). Dengue and severe dengue [internet].

2014 [updated 2014 Mar; cited 2014 Nov 2]. Available from:

http://www.who.int/mediacentre/factsheets/fs117/en/

2. Sukohar A. Demam Berdarah Dengue (DBD). Medula Unila. 2014; 2(2):1-15

3. World Health Organization

(WHO). Comprehensive guidelines for prevention

and control of Dengue and Dengue Haemorrhagic Fever. India: Regional

Office for South-East Asia. 2011

4. Pusat Data dan Surveilans Epidemiologi Kementerian Kesehatan RI. Buletin

Jendela Epidemiologi Topik Utama Demam Berdarah Dengue. Jakarta:

Buletin Jendela Epidemiologi. 2010; 2:1-4

5. Supriyantoro, Primadi O, Sitohang V, Budijanto D, Hardhana B, Soenardi TA,

dkk. Profil Kesehatan Indonesia tahun 2014. Jakarta: Kementerian Kesehatan

Republik Indonesia. 2014

6. Dinas Kesehatan Provinsi Jawa Tengah. Profil esehatan Provinsi Jawa Tengah

tahun 2012 [internet]. 2012 [updated 2012; cited 2014 Sept]. Available from:

http://www.dinkesjatengprov.go.id/dokumen/2013/SDK/Mibangkes/profil201

2/BAB_I-VI_2012_fix.pdf

7. Namongsa V, Sirivichayakul C, Songsithichok S, Chanthavanich P,

Chokejindachai W, Sitcharungsi R, dkk. Differences in Clinical Features

Between Children and Adults with Dengue Hemorrhagic Fever/ Dengue

Shock Syndrome. Thailand: Southest Asian J Trop Med Public Health. 2013;

44(5):772-9

8. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, Mercado JC, dkk.

Differences in Dengue Severityin Infants, Children, and Adult in A 3-Year

Hospital-Based Study in Nicaragua. Nicaragua: Am J Trop Med Hyg. 2005;

73(6): 1063-1070

9. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K,

Sukthana Y, Pukrittayakame S. Risk factor and clinical features associated

(2)

with Severe Dengue Infection in adult and children during the 2011 epidemic

in Chonburi, Thailand. Thailand: Trop med Int Health. 2004

10. Aggarwal A, Chandra J, Aneja S, Patwari AK, Dutta AK. An Epidemiologic

of Dengue Haemorrhagic Fever and Dengue Shock Syndrome in Children in

Delhi. Delhi: Indian Pediatr. 1998; 35(8):727-32

11. Bhaskar ME, Moorthy S, Kumar S. Dengue Haemorrhagic fever among adults

– An Observational study in Chennai, south India. India: Indian J Med Res.

2010; 132(6):738-740

12. Shepherd, Moore S. Dengue [internet]. 2014 [updated 2014 Mar 14, cited

2014 Sep]. Available from:

http://emedicine.medscape.com/article/215840-overview

13. Candra, Aryu. Demam Berdarah Dengue: Epidemiologi, Patogenesis, dan

factor Risiko Penularan. Semarang: FK UNDIP. 2010

14. Hasibuan, WS. Chapter II [online]. 2010 [cited 2015 Feb 7]; Available from:

http://repository.usu.ac.id/bitstream/123456789/20820/4/Chapter%20II.pdf

15. Silitonga, ML. Chapter I [Online]. 2011 [cited 2015 Feb 7]; Available from:

http://repository.usu.ac.id/bitstream/123456789/20820/4/Chapter%20II.pdf

16. Dadiyanto DW, Muryawan H, Anindita. Buku Ajar Ilmu Kesehatan Anak.

Semarang: Badan Penerbit Universitas Diponegoro. 2011

17. Halstead SB. Pathogenesis of dengue: Challenges to molecular biology.

Puerto Rico: Science. 1988; 239(4839):476-481

18. WHO. Water-related Disease Dengue and Dengue Haemorrhagic Fever

[internet].

2015

[cited

2015

Jan

13].

Available

from:

http://www.who.int/water_sanitation_health/diseases/dengue/en/

19. Dengue Fever Investigation Guideline. Kansas Disease Investigation

Guideline

[internet].

2010

[cited

2014

Nov].

Available

from:

http://www.kdheks.gov/epi/Investigation_Guidelines/Dengue_Fever_Investiga

tion_Guideline.pdf

20. Chuansumrit A, Tangnararatchakit K. Pathophysiology and management of

Dengue Hemorrhagic Fever. Bangkok: Transfusion Alternatives in

Transfusion Medicine. 2005

(3)

21. Centers of Disease Control and Prevention (CDC). Clinical Guidance

[internet]. 2014 [updated June 2014; cited 2015 Feb 5]. Available from:

www.cdc.gov/dengue/clinicalLab/clinical.html

22. Behrman, Kliegman, Arvin. Nelson Ilmu Kesehatan Anak. Jakarta: Penerbit

Buku Kedokteran EGC. 2000

23. Tsai JJ, Chokephaibulkit K, Chen PC, Liu LT, Hsiao HM, Lo YC, dkk. Role

of Cognitive Parameters in Dengue Hemorrhagic Fever and Dengue Shock

Syndrome. Taiwan: Journal Biomedical Science. 2013; 20(1):88

24. Noisakran S, Perng GC. Alternate Hypothesis on the Pathogenesis of Dengue

Hemorrhagic Fever (DHF)/ Dengue Shock Syndrome (DSS in Dengue Virus

Infection. Atlanta: Biol Med. 2008; 233:401-408

25. Leon LR. Invited review: cytokine Regulation of Fever: Study Using gene

Knockout Mice. Massachusetts (Amerika): J Appl Physiol. 2002;

92:2648-2655

26. World Health Organization

(WHO).Handbook For Clinical Management of

Dengue. Geneva: WHO Press. 2012

27. Wahid SFSA, Sanusi S, Zawawi MM, Ali RA. A Comparison of the Pattern of

Liver Involvement in Dengue Hemorrhagic Fever with Classic Dengue Fever.

Malaysia: Southeast Asian J Trop Med Public Health. 2000; 31(2):259-263

28. Garna, H Herry. Buku Ajar Divisi Infeksi Virus dan Penyakit Tropis. Jakarta:

Sagung Seto. 2012

29. World Health Organization

(WHO). Dengue Haemorrhagic Fever Diagnosis,

Treatment, Prevention and Control Second Edition. Geneva: WHO press.

1997

30. Dhooria GS, Bhat D, Bains HS. Clinical profile and outcome in children of

Dengue Hemorrhagic Fever in North India. Iran J Pediatr. 2008;

18(3):222-228

31. Sahidulalam ABM, Sadat SA, Swapan Z, Ahmed AU, Karim MDN, Paul HK,

dkk. Clinical profile of dengue fever in children. Bangladesh J Child Health.

2009; 33(2):55-58

(4)

32. Ratageri VH, Shepur TA, Wari PK, Chavan SC, Mujahid IB, Yergolkar PN.

Clinical profile and outcome of Dengue Fever cases. Indian Journal of

Pediatrics. 2005;72(8):705-706

33. Ahmed S, Arif F, Yahya Y, Rehman A, Abbas K, Ashraf S, dkk. Dengue

Fever Outbreak in Karachi 2006

–

A study of profile and outcome of children

under 15 years of age. J Pak Med Assoc. 2008; 58(1):4-8

34. Guilarde AO, Turchi MD, Siqueira JB, Feres VCR, Rocha B, Levi JE, dkk.

Dengue and Dengue Hemorrhagic Fever among adult: clinical outcomes

related to viremia, serotypes, and antibody response. Brazil: The Journal of

Infection Diseases. 2008

35. Tee HP, How SH, Jamalludin AR, Safhan MNF, Sapian MM, Kuan YC, dkk.

Associated with Development of Dengue Haemorrhagic Fever or Dengue

Shock Syndrome in Adults in Hospital Tengku Ampuan Afzan Kuantan.

Pahang: Mcd J Malaysia. 2009; 64: 316-320

36. Pawitan JA. Dengue Unfection: Predictors for Severe Dengue. Jakarta: Acta

Med Indones-Indones J Intern Med. 2011

37. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of

Age on outcome of Secondary Dengue 2 Infection. Cuba: Int J Infect Dis.

2002; 6(2):118-124

38. Chua MN, dkk. Prothrombin time and partial thromboplastin time as a

predictor of bleeding in patients with Dengue Hemorrhagic Fever. Filipina:

Southeast Asian J Trop Med Public Health. 1993; 24(1):141-143

39. Setiati TE, Wagenaar JFP, Kruif MD, Mairuhu ATA, Corp ECM, Soemantri

A. Changing epidemiology of Dengue Heaemorrhagic Fever in Indonesia.

Jakarta: Dengue Buletin. 2006; 30:1-4

40. Halstead, Scott B. Dengue. Amerika: Imperial College Press. 2008

41. Setiati, Tatty Ermin, Soemantri. Manifestasi klinis kegawatan anak.

Semarang: Pelita Insani. 2010

42. Kresno SB. Respons imun terhadap infeksi virus. In:

Imunologi

– Diagnosis

dan Prosedur Laboratorium.

Jakarta : FK UI. 2001

(5)

43. Immunopaedia. Paediatrics and Adult Immune System [internet]. 2008 [cited

2015

Juli

2].

Available

from:

http://immunopaedia.org.za/fileadmin/docs/2008-09-05-00_Paediatrics%20and%20adult%20immune%20system.pdf

44. Suharti, C. Sudoyo, Aru W. Setiyohadi, Bambang. Alwi, Idrus. Simadibrata

K, Marcellus. Setiati, Siti.

Dasar-dasar Hemostasis dalam

Buku Ajar Ilmu

Penyakit Dalam Edisi IV

. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit

Dalam FKUI. 2007

45. Fleisher, GR, Ludwig S, dkk. Textbook of Pediatric Emergency Medicine.

Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health. 2010

46. Soedarmo PS dkk. Infeksi Virus Dengue. Dalam: Soedarmo.

Buku Ajar Ilmu

Kesehatan Anak, Infeksi dan Penyakit Tropis Edisi Pertama.

Jakarta: IDAI.

2002; 176-208

47. Setiati, Tatty Ermin, Soemantri. Demam Berdarah Dengue pada anak:

patofisiologi, resusitasi mikrovaskuler dan terapi komponen darah. Semarang :

Pelita Insani. 2009

48. Hadinegoro, Sri Rezeki H., Hindra Irawan S. Demam Berdarah Dengue.

Jakarta: Fakultas Kedokteran Universitas Indonesia. 2005

49. Smith DR dan Khakpoor A. Involvement of the liver in dengue infections.

Thailand: Dengue Bulletin. 2009;33:75-86

50. Mourao MPGM dkk. Dengue Hemorrhagic Fever and Acute Hepatitis. Brazil

J Infect Dis Salvador. 2004;8(6):461-464

(6)

78 LAMPIRAN

(7)

(8)

(9)

Lampiran 3.

Output uji statistik

Analisis subjek penelitian

Descriptives

Kategori Usia Statistic Std. Error

Usia Responden Anak Mean 7.9908 .51595 95% Confidence Interval for Mean Lower Bound 6.9636 Upper Bound 9.0179 5% Trimmed Mean 7.9280 Median 7.6700 Variance 21.030 Std. Deviation 4.58586 Minimum .42 Maximum 17.17 Range 16.75 Interquartile Range 7.00 Skewness .123 .271 Kurtosis -.723 .535 Dewasa Mean 34.1181 1.40117 95% Confidence Interval for Mean Lower Bound 31.3262 Upper Bound 36.9100 5% Trimmed Mean 33.2163 Median 31.1700 Variance 147.246 Std. Deviation 12.13449 Minimum 19.50 Maximum 70.00 Range 50.50 Interquartile Range 11.92 Skewness 1.323 .277 Kurtosis .865 .548

Deskripsi karakteristik subjek penelitian

Kategori Usia * Jenis Kelamin Crosstabulation

Count

Jenis Kelamin Total

Laki-laki Perempuan

Kategori Usia

Anak 34 45 79

Dewasa 36 39 75

(10)

Chi-Square Tests

Value df Asymp. Sig.

(2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square .382a 1 .536 Continuity Correctionb .208 1 .648 Likelihood Ratio .382 1 .536

Fisher's Exact Test .628 .324

Linear-by-Linear Association

.380 1 .538

N of Valid Cases 154

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 34,09. b. Computed only for a 2x2 table

Kategori Usia * Status Gizi Crosstabulation

Count

Status Gizi Total

Gizi Baik Berisiko Malnutrisi Kategori Usia Anak 65 14 79 Dewasa 60 15 75 Total 125 29 154 Chi-Square Tests

Value df Asymp. Sig.

(2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square .131a 1 .718 Continuity Correctionb .024 1 .877 Likelihood Ratio .131 1 .718

.130 1 .719

(11)

Deskripsi dan analisis bivariat profil klinis subjek penelitian

Kelompok Usia * Lama Demam Crosstabulation

Lama Demam Total

<=4 hari >4 hari

Kelompok Usia

<5 tahun

Count 4 17 21

% within Kelompok Usia 19.0% 81.0% 100.0%

5-14 tahun

Count 15 35 50

14-19 tahun

Count 0 8 8

>19 tahun

Count 13 62 75

Total

Count 32 122 154

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square 1.055a 1 .304 Continuity Correctionb .686 1 .408 Likelihood Ratio 1.061 1 .303

Linear-by-Linear Association 1.048 1 .306

Report

Jumlah Hari Demam

Kategori Usia

Mean N Std.

Deviation

Median Minimum Maximum Range Variance % of Total N

Anak 5.92 79 2.231 5.00 3 16 13 4.977 51.3%

Dewasa 6.61 75 2.229 6.00 3 13 10 4.970 48.7%

(12)

Test Statisticsa Jumlah Hari Demam Mann-Whitney U 2309.500 Wilcoxon W 5469.500 Z -2.395

Asymp. Sig. (2-tailed) .017

a. Grouping Variable: Kategori Usia

Kelompok Usia * Perdarahan Spontan Crosstabulation

Perdarahan Spontan Total

Tidak Ya

Kelompok Usia

<5 tahun

Count 6 15 21

5-14 tahun

Count 21 29 50

14-19 tahun

Count 5 3 8

>19 tahun

Count 50 25 75

Total

Count 82 72 154

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square 10.577a 1 .001 Continuity Correctionb 9.552 1 .002 Likelihood Ratio 10.711 1 .001

(13)

Kelompok Usia * Peteki Crosstabulation Peteki Total Tidak Ya Kelompok Usia <5 tahun Count 10 11 21

5-14 tahun

Count 23 27 50

14-19 tahun

Count 5 3 8

>19 tahun

Count 58 17 75

Total

Count 96 58 154

(14)

Kelompok Usia * Ekimosis / Purpura Crosstabulation

Ekimosis / Purpura Total

Tidak Ya

Kelompok Usia

<5 tahun

Count 17 4 21

5-14 tahun

Count 45 5 50

14-19 tahun

Count 8 0 8

>19 tahun

Count 74 1 75

Total

Count 144 10 154

a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,87. b. Computed only for a 2x2 table

(15)

Kelompok Usia * Epistaksis Crosstabulation Epistaksis Total Tidak Ya Kelompok Usia <5 tahun Count 18 3 21

5-14 tahun

Count 41 9 50

14-19 tahun

Count 7 1 8

>19 tahun

Count 70 5 75

Total

Count 136 18 154

(16)

Kelompok Usia * Perdarahan Gusi Crosstabulation

Perdarahan Gusi Total

Tidak Ya

Kelompok Usia

<5 tahun

Count 19 2 21

5-14 tahun

Count 50 0 50

14-19 tahun

Count 8 0 8

>19 tahun

Count 71 4 75

Total

Count 148 6 154

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square .807a 1 .369 Continuity Correctionb .232 1 .630 Likelihood Ratio .819 1 .365

Linear-by-Linear Association .801 1 .371

(17)

Kelompok Usia * Hematemesis Crosstabulation Hematemesis Total Tidak Ya Kelompok Usia <5 tahun Count 18 3 21

5-14 tahun

Count 48 2 50

14-19 tahun

Count 8 0 8

>19 tahun

Count 74 1 75

Total

Count 148 6 154

(18)

Kelompok Usia * Melena Crosstabulation Melena Total Tidak Ya Kelompok Usia <5 tahun Count 19 2 21

5-14 tahun

Count 49 1 50

14-19 tahun

Count 8 0 8

>19 tahun

Count 70 5 75

Total

Count 146 8 154

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square .643a 1 .423 Continuity Correctionb .192 1 .661 Likelihood Ratio .648 1 .421

Linear-by-Linear Association .639 1 .424

(19)

Kelompok Usia * Hepatomegali Crosstabulation Hepatomegali Total Tidak Ya Kelompok Usia <5 tahun Count 6 15 21

5-14 tahun

Count 26 24 50

14-19 tahun

Count 7 1 8

>19 tahun

Count 71 4 75

Total

Count 110 44 154

(20)

Kelompok Usia * Syok Crosstabulation Syok Total Tidak Ya Kelompok Usia <5 tahun Count 14 7 21

5-14 tahun

Count 42 8 50

14-19 tahun

Count 8 0 8

>19 tahun

Count 74 1 75

Total

Count 138 16 154

(21)

Kelompok Usia * Kebocoran Plasma Crosstabulation

Kebocoran Plasma Total

Tidak Ya

Kelompok Usia

<5 tahun

Count 2 19 21

5-14 tahun

Count 8 42 50

14-19 tahun

Count 3 5 8

>19 tahun

Count 44 31 75

Total

Count 57 97 154

(22)

Kelompok Usia * Hemokonsentrasi Crosstabulation Hemokonsentrasi Total Tidak Ya Kelompok Usia <5 tahun Count 11 10 21

5-14 tahun

Count 25 25 50

14-19 tahun

Count 5 3 8

>19 tahun

Count 53 22 75

Total

Count 94 60 154

(23)

Kelompok Usia * Efusi Pleura Crosstabulation

Efusi Pleura Total

Tidak Ya

Kelompok Usia

<5 tahun

Count 7 14 21

5-14 tahun

Count 21 29 50

14-19 tahun

Count 5 3 8

>19 tahun

Count 62 13 75

Total

Count 95 59 154

(24)

Kelompok Usia * Asites Crosstabulation Asites Total Tidak Ya Kelompok Usia <5 tahun Count 18 3 21

5-14 tahun

Count 48 2 50

14-19 tahun

Count 7 1 8

>19 tahun

Count 74 1 75

Total

Count 147 7 154

Value Df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square 3.477a 1 .062 Continuity Correctionb 2.183 1 .140 Likelihood Ratio 3.865 1 .049

(25)

Kelompok Usia * Edema Palpebra Crosstabulation

Edema Palpebra Total

Tidak Ya Kelompok Usia <5 tahun Count 9 12 21 % within Kelompok Usia 42.9% 57.1% 100.0% 5-14 tahun Count 29 21 50 % within Kelompok Usia 58.0% 42.0% 100.0% 14-19 tahun Count 8 0 8 % within Kelompok Usia 100.0% 0.0% 100.0% >19 tahun Count 75 0 75 % within Kelompok Usia 100.0% 0.0% 100.0% Total Count 121 33 154 % within Kelompok Usia 78.6% 21.4% 100.0% Chi-Square Tests

39.614 1 .000

a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 16,07.

(26)

Kelompok Usia * Derajat Penyakit DBD Crosstabulation

Test Statisticsa

Derajat Penyakit DBD

Most Extreme Differences

Absolute .285

Positive .000

Negative -.285

Kolmogorov-Smirnov Z 1.767

Asymp. Sig. (2-tailed) .004

a. Grouping Variable: Kategori Usia

Derajat Penyakit DBD Total

Derajat 1 Derajat 2 Derajat 3 Derajat 4

Kelompok Usia <5 tahun Count 4 10 4 3 21 % within Kelompok Usia 19.0% 47.6% 19.0% 14.3% 100.0% 5-14 tahun Count 17 25 5 3 50 % within Kelompok Usia 34.0% 50.0% 10.0% 6.0% 100.0% 14-19 tahun Count 6 2 0 0 8 % within Kelompok Usia 75.0% 25.0% 0.0% 0.0% 100.0% >19 tahun Count 47 27 0 1 75 % within Kelompok Usia 62.7% 36.0% 0.0% 1.3% 100.0% Total Count 74 64 9 7 154 % within Kelompok Usia 48.1% 41.6% 5.8% 4.5% 100.0%

(27)

Analisis multivariat subjek penelitian

Variables in the Equation

B S.E. Wald df Sig. Exp(B) 95% C.I.for

EXP(B) Lower Upper Step 1a PerdSpontan(1) 1.649 .967 2.910 1 .088 5.202 .782 34.595 Hepatomegali(1) 2.379 .630 14.237 1 .000 10.789 3.136 37.118 Syok(1) .749 1.211 .382 1 .536 2.114 .197 22.688 Leakage(1) 1.079 .433 6.209 1 .013 2.941 1.259 6.870 Derajat 1.191 2 .551 Derajat(1) -1.068 .978 1.191 1 .275 .344 .051 2.339 Derajat(3) -19.758 11918.1 61 .000 1 .999 .000 .000 . Constant -3.297 1.250 6.959 1 .008 .037 Step 2a PerdSpontan(1) 1.525 .922 2.738 1 .098 4.596 .755 27.988 Hepatomegali(1) 2.427 .631 14.810 1 .000 11.324 3.290 38.976 Leakage(1) 1.102 .431 6.538 1 .011 3.010 1.293 7.006 Derajat .970 2 .616 Derajat(1) -.909 .923 .970 1 .325 .403 .066 2.460 Derajat(3) -20.345 11959.5 50 .000 1 .999 .000 .000 . Constant -2.642 .614 18.492 1 .000 .071 Step 3a PerdSpontan(1) .671 .403 2.779 1 .096 1.957 .889 4.310 Hepatomegali(1) 2.411 .586 16.917 1 .000 11.148 3.533 35.173 Leakage(1) 1.157 .427 7.351 1 .007 3.179 1.378 7.336 Constant -2.709 .575 22.176 1 .000 .067

(28)

B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B)

Lower Upper Step 1a Peteki(1) 1.104 .368 8.977 1 .003 3.016 1.465 6.209 Ekimosis(1) 1.682 1.134 2.199 1 .138 5.376 .582 49.665 Epistaksis(1) .618 .593 1.085 1 .298 1.855 .580 5.930 Hematemesis(1) .388 1.306 .088 1 .766 1.474 .114 19.078 Constant -3.290 1.567 4.407 1 .036 .037 Step 2a Peteki(1) 1.112 .368 9.137 1 .003 3.040 1.478 6.250 Ekimosis(1) 1.773 1.096 2.618 1 .106 5.887 .688 50.409 Epistaksis(1) .617 .592 1.083 1 .298 1.853 .580 5.917 Constant -3.003 1.188 6.390 1 .011 .050 Step 3a Peteki(1) 1.175 .363 10.465 1 .001 3.238 1.589 6.597 Ekimosis(1) 1.814 1.090 2.771 1 .096 6.135 .725 51.938 Constant -2.530 1.079 5.498 1 .019 .080

a. Variable(s) entered on step 1: Peteki, Ekimosis, Epistaksis, Hematemesis.

B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B)

Lower Upper Step 1a Hemokonsentrasi(1) .332 .429 .599 1 .439 1.393 .602 3.228 EfusiPleura(1) 1.713 .427 16.116 1 .000 5.548 2.403 12.807 Asites(1) .168 1.619 .011 1 .918 1.182 .050 28.230 EdemPalp(1) 21.353 6618.660 .000 1 .997 1876857696.085 .000 . Constant -22.375 6618.660 .000 1 .997 .000 Step 2a Hemokonsentrasi(1) .334 .428 .608 1 .435 1.396 .603 3.231 EfusiPleura(1) 1.715 .426 16.180 1 .000 5.559 2.410 12.822 EdemPalp(1) 21.360 6622.623 .000 1 .997 1890447480.171 .000 . Constant -22.220 6622.623 .000 1 .997 .000 Step 3a EfusiPleura(1) 1.737 .425 16.691 1 .000 5.678 2.468 13.061 EdemPalp(1) 21.435 6629.401 .000 1 .997 2036970950.189 .000 . Constant -22.089 6629.401 .000 1 .997 .000

(29)

(30)

(31)